So far in 2025, the Trump administration has cut more than $1 billion in NIH grants. That includes a study on sickle cell ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 ...

The enrolment for phase III clinical trials of India's first dengue vaccine, DengiAll, is expected to be completed by October ...

Lawmakers probe University of Michigan for handling biological smuggling claims linked to Chinese researchers.

Products deemed unsafe remain for sale despite a sharp rise in safety warnings issued by the federal watchdog agency tasked ...

We don't have $3.8 billion to spend on the pursuit of cures for illness but we have $75 billion for the work of ICE? What a ...

Saturday on PBS News Weekend, a new analysis reveals FEMA missed major flood risks at Camp Mystic where dozens died in the Texas floods. How NIH funding cuts are raising concerns about research ...

Using a variety of models helps to ensure that the best research is being done to benefit patients and their families.

Columbia University is set to settle with the Trump administration over alleged civil rights violations, agreeing to pay ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for completion by October.